Correlation Between Unicycive Therapeutics and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Edgewise Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Edgewise Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Edgewise Therapeutics
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Unicycive and Edgewise is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Edgewise Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 0.73 times more return on investment than Edgewise Therapeutics. However, Unicycive Therapeutics is 1.37 times less risky than Edgewise Therapeutics. It trades about 0.25 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about 0.15 per unit of risk. If you would invest 34.00 in Unicycive Therapeutics on September 4, 2024 and sell it today you would earn a total of 40.00 from holding Unicycive Therapeutics or generate 117.65% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Edgewise Therapeutics
Performance |
| Timeline |
| Unicycive Therapeutics |
| Edgewise Therapeutics |
Unicycive Therapeutics and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Edgewise Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Edgewise Therapeutics vs. Candel Therapeutics | Edgewise Therapeutics vs. Cingulate Warrants | Edgewise Therapeutics vs. Unicycive Therapeutics | Edgewise Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |